Skip to main content
Have a personal or library account? Click to login
Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients Cover

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients

Balkan Journal of Medical Genetics
Volume 15 (2012): Issue Supplement (December 2012)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Dec 2012
References

References

  1. 1. Miki Y, Swensen J, Shattuck-Eidens D,A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182): 66-71.
    Open DOISearch in Google Scholar
  2. 2. Wooster R, Bignell G, Lancaster J,Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995; 378(6559): 789-792.
    Open DOISearch in Google Scholar
  3. 3. Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007; 11(2): 103-5.
    Open DOISearch in Google Scholar
  4. 4. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7(12): 937-948.
    Open DOISearch in Google Scholar
  5. 5. Ferla R, Calo V, Cascio S,Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007; 18 (Suppl 6): vi93-98.
    Open DOISearch in Google Scholar
  6. 6. Balmana J, Diez O, Castiglione M. BRCA in breast cancer: ESMO clinical recommendations. Ann Oncol. 2009; 20(Suppl 4): 19-20.
    Open DOISearch in Google Scholar
  7. 7. De Greve J, Sermijn E, De Brakeleer S, Ren Z, Teugels E. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol. 2008; 20(6): 605-613.
    Open DOISearch in Google Scholar
  8. 8. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010; 10(4): 293-301.
    Open DOISearch in Google Scholar
  9. 9. Byrski T, Gronwald J, Huzarski T,Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol. 2010; 28(3): 375-379.
    Open DOISearch in Google Scholar
  10. 10. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2000; 2(2): 77-81.
    Open DOISearch in Google Scholar
  11. 11. Freedman ML, Penney KL, Stram DO,A haplotype- based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res. 2005; 65(16): 7516-7522.
    Open DOISearch in Google Scholar
  12. 12. Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: A literature review. Genet Mol Biol. 2009; 32(3): 437-446.
    Open DOISearch in Google Scholar
  13. 13. Cox DG, Kraft P, Hankinson SE, Hunter DJ. Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res. 2005; 7(2): R171-R175.
    Open DOISearch in Google Scholar
  14. 14. Qiu LX, Yao L, Xue K,BRCA2 N372H polymorphism and breast cancer susceptibility: a metaanalysis involving 44,903 subjects. Breast Cancer Res Treat. 2010; 123(2): 487-490.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10034-012-0025-8 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 81 - 85
Published on: Dec 22, 2012
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
BRCA1 and BRCA2 genes,
Breast cancer,
Macedonian patients,
Polymorphisms
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2012 Dijana Plaseska-Karanfilska, I Maleva, S Madjunkova, G Bozhinovski, E Smickova, G Kondov, Z Spiroski, A Arsovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 15 (2012): Issue Supplement (December 2012)
Previous article
Next article